/stocks — the workspaceLOADING
All IRON SEC filings, by type → · Earnings date & implied move · Search inside filings
Disc Medicine, Inc. (IRON) is a pharmaceutical preparations company. 9 insider Form 4 filings in the last 90 days. Next earnings projected around 2026-11-05 from IRON's year-over-year reporting pattern (not yet company-confirmed). Fundamentals from SEC filings; prices are end-of-day.
What’s behind IRON’s latest move — the size, how unusual the volume is, and the catalyst on the tape, explained and cited to the source.
End-of-day bars · delayed, not real-time · data: Databento · studies computed in your browser from these barsCharting by TradingView Lightweight Charts™
XBRL company facts, SEC EDGAR. TTM = last four reported quarters. Valuation ratios arrive with a price source — we don't fake quotes.
Estimates, not targets. The DCF treats free cash flow as cash flow to equity and divides by shares (the common retail shortcut — it skips net debt and a full WACC), so it’s a sanity-check, not a valuation opinion. All inputs are from IRON’s SEC filings; change any assumption above and the numbers update live. Educational only — not investment advice.
Not reported in XBRL for this filer.
A plain-English read on IRON plus an auto-SWOT — built from IRON's SEC filings and market data, every point cited, nothing invented. Educational, not investment advice.
Four AI analysts — a bull, a bear, a risk manager, and a PM — debate IRON using only the SEC-filing and market facts below. Every point cites its evidence; nothing is invented. This is educational research, not investment advice.
Educational only — not financial advice. Data from SEC EDGAR public filings; no live market data is shown. Figures reflect the company's own reported XBRL facts and may lag.
Has IRON been issuing shares? Offering history →
↓ Download the fiscal-year statement table (XLSX) · revenue, income, EPS, cash flow, balance sheet · from SEC XBRL, dated
No lawmaker has disclosed a trade in IRON under the STOCK Act.
Projected from IRON's own SEC 8-K filing history — the year-over-year reporting pattern (about 47% land the exact day, about 91% within a week, measured across 4,713 past reports). No analyst estimates and nothing invented, and every confirmed date links to the source it came from, so you can check it yourself. It upgrades the momentIRON files or announces.
IRON's earnings reaction has been evenly split — 4 up, 4 down across its last 8 reports.
Each figure is one earnings reaction — how much IRON moved from the closing price the day before a report to the close the day after. Based on its last 8 reports.
Earnings reactions have been moderate.
A more typical earnings reaction has been approximately ±3.6%.
Realized close-to-close history only — no options-implied move, no analyst estimates.
| Reported | Close-to-close |
|---|---|
| 2026-07-30 | +4.5% |
| 2026-05-05 | +1.5% |
| 2026-02-26 | -0.4% |
| 2025-11-06 | -5.1% |
| 2025-08-07 | -1.6% |
| 2025-05-07 | +4.0% |
| 2025-02-27 |
Earnings dates are the company's 8-K Item 2.02 filings (SEC). Reactions from Databento EOD.
| +3.2% |
| 2024-11-12 | -5.3% |
No tracked institution reported a position in IRON in the latest 13F round.
Every registered fund files its complete portfolio with the SEC. These weights come from those filings, so each one carries the period it describes. Holdings are quarterly and filed in arrears — the figures below are as of 2026-06-30, not today.
| Fund | Weight | As of |
|---|---|---|
| IWM iShares Russell 2000 ETF | 0.07% | 2026-06-30 |
| ITOT iShares Core S&P Total US Stock Market ETF | <0.01% | 2026-06-30 |
| VTI Vanguard Total Stock Market ETF | <0.01% | 2026-06-30 |
Drawn from 39 large US equity funds we scan, not every fund in existence, so a missing fund means we do not scan it rather than that it holds none. Holdings are joined to tickers by issuer name, which does not resolve every position; what that misses is published.
Head office: Watertown, Massachusetts, United States · the company’s charter and its head office are in different states.
Source: the cover page of Disc Medicine, Inc.’s 10-Q filed 2026-07-30, on EDGAR. Filings checked 2026-10-21. Incorporation is where the company’s charter was filed. It is not where the business operates or earns, which no filing cover states. How this works
Of 16 sales in the last ~6 months, 15 were filed with the Rule 10b5-1 box checked, set up in advance under a written trading plan; 1 was filed without it.
| Bitterman KevinDirector | SELLplan | $3.4M | view → |
| Bitterman KevinDirector | SELL | $1.9M | view → |
| Bitterman KevinDirector | SELLplan | $135K | view → |
| Bitterman KevinDirector | SELLplan | $4.4M | view → |
| Yu Jonathan Yen-WenChief Operating Officer | SELLplan | $756K | view → |
| Quisel John DChief Executive Officer | SELLplan | $2.6M | view → |
| Yu Jonathan Yen-WenChief Operating Officer | SELLplan | $66K | view → |
| Khara RahulChief Legal Officer | SELLplan | $400K | view → |
From SEC Form 4 and 13F filings. Both are backward-looking disclosures on different reporting clocks, and neither predicts price. Educational information only — not investment advice.